Melanocortin 1 Receptor Regulates Pathological and Physiological Cardiac Remodeling

Background The melanocortin 1 receptor (MC1R) is abundantly expressed in the skin and leukocytes, where it regulates skin pigmentation and inflammatory responses. Recently, MC1R was also found in the heart, but its functional role has remained unknown. We aimed to investigate whether MC1R is involve...

Full description

Saved in:
Bibliographic Details
Main Authors: Anni Suominen, Aino Suni, Saku Ruohonen, Zoltán Szabó, Lotta Pohjolainen, Minying Cai, Eriika Savontaus, Virpi Talman, Risto Kerkelä, Petteri Rinne
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.037961
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850185307068039168
author Anni Suominen
Aino Suni
Saku Ruohonen
Zoltán Szabó
Lotta Pohjolainen
Minying Cai
Eriika Savontaus
Virpi Talman
Risto Kerkelä
Petteri Rinne
author_facet Anni Suominen
Aino Suni
Saku Ruohonen
Zoltán Szabó
Lotta Pohjolainen
Minying Cai
Eriika Savontaus
Virpi Talman
Risto Kerkelä
Petteri Rinne
author_sort Anni Suominen
collection DOAJ
description Background The melanocortin 1 receptor (MC1R) is abundantly expressed in the skin and leukocytes, where it regulates skin pigmentation and inflammatory responses. Recently, MC1R was also found in the heart, but its functional role has remained unknown. We aimed to investigate whether MC1R is involved in the regulation of pathological or physiological cardiac remodeling. Methods and Results Recessive yellow mice, as a model of global MC1R deficiency, and cardiomyocyte‐specific MC1R knockout mice were subjected to transverse aortic constriction or voluntary wheel running to induce pathological or physiological cardiac hypertrophy, respectively. Mice were phenotyped for cardiac structure and function by echocardiography, histology, and quantitative PCR analysis. H9c2 cells and neonatal mouse ventricular cardiac myocytes were used as in vitro models to investigate the effects of pharmacological MC1R activation on hypertrophy‐related responses. We found that the expression of MC1R progressively declines in the failing mouse heart. MC1R recessive yellow mice showed blunted hypertrophic response to transverse aortic constriction–induced pressure overload and exercise training. This phenotype was recapitulated in MC1R knockout mice, demonstrating that MC1R deficiency specifically in cardiomyocytes is responsible for the antihypertrophic effect. However, MC1R knockout mice subjected to pressure overload showed left ventricular dilatation that was associated with reduced ejection fraction and changes in left ventricular diastolic function. At the molecular level, the mRNA expression of myosin heavy chain β was upregulated in the hearts of MC1R knockout mice. In contrast, selective activation of MC1R promoted hypertrophic responses in cultured cardiomyocytes. Conclusions Cardiomyocyte‐specific MC1R deficiency attenuates physiological and pathological cardiac hypertrophy in mice, while pharmacological activation of MC1R promotes cardiomyocyte hypertrophy.
format Article
id doaj-art-ff975aa9bba6438b92aad87a62e7761e
institution OA Journals
issn 2047-9980
language English
publishDate 2025-02-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj-art-ff975aa9bba6438b92aad87a62e7761e2025-08-20T02:16:45ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802025-02-0114410.1161/JAHA.124.037961Melanocortin 1 Receptor Regulates Pathological and Physiological Cardiac RemodelingAnni Suominen0Aino Suni1Saku Ruohonen2Zoltán Szabó3Lotta Pohjolainen4Minying Cai5Eriika Savontaus6Virpi Talman7Risto Kerkelä8Petteri Rinne9Research Centre for Integrative Physiology & Pharmacology, Institute of Biomedicine University of Turku FinlandResearch Centre for Integrative Physiology & Pharmacology, Institute of Biomedicine University of Turku FinlandResearch Centre for Integrative Physiology & Pharmacology, Institute of Biomedicine University of Turku FinlandResearch Unit of Biomedicine and Internal Medicine, Department of Pharmacology and Toxicology University of Oulu FinlandDrug Research Program and Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy University of Helsinki FinlandDepartment of Chemistry and Biochemistry University of Arizona Tucson AZ USAResearch Centre for Integrative Physiology & Pharmacology, Institute of Biomedicine University of Turku FinlandResearch Centre for Integrative Physiology & Pharmacology, Institute of Biomedicine University of Turku FinlandResearch Unit of Biomedicine and Internal Medicine, Department of Pharmacology and Toxicology University of Oulu FinlandResearch Centre for Integrative Physiology & Pharmacology, Institute of Biomedicine University of Turku FinlandBackground The melanocortin 1 receptor (MC1R) is abundantly expressed in the skin and leukocytes, where it regulates skin pigmentation and inflammatory responses. Recently, MC1R was also found in the heart, but its functional role has remained unknown. We aimed to investigate whether MC1R is involved in the regulation of pathological or physiological cardiac remodeling. Methods and Results Recessive yellow mice, as a model of global MC1R deficiency, and cardiomyocyte‐specific MC1R knockout mice were subjected to transverse aortic constriction or voluntary wheel running to induce pathological or physiological cardiac hypertrophy, respectively. Mice were phenotyped for cardiac structure and function by echocardiography, histology, and quantitative PCR analysis. H9c2 cells and neonatal mouse ventricular cardiac myocytes were used as in vitro models to investigate the effects of pharmacological MC1R activation on hypertrophy‐related responses. We found that the expression of MC1R progressively declines in the failing mouse heart. MC1R recessive yellow mice showed blunted hypertrophic response to transverse aortic constriction–induced pressure overload and exercise training. This phenotype was recapitulated in MC1R knockout mice, demonstrating that MC1R deficiency specifically in cardiomyocytes is responsible for the antihypertrophic effect. However, MC1R knockout mice subjected to pressure overload showed left ventricular dilatation that was associated with reduced ejection fraction and changes in left ventricular diastolic function. At the molecular level, the mRNA expression of myosin heavy chain β was upregulated in the hearts of MC1R knockout mice. In contrast, selective activation of MC1R promoted hypertrophic responses in cultured cardiomyocytes. Conclusions Cardiomyocyte‐specific MC1R deficiency attenuates physiological and pathological cardiac hypertrophy in mice, while pharmacological activation of MC1R promotes cardiomyocyte hypertrophy.https://www.ahajournals.org/doi/10.1161/JAHA.124.037961cardiac hypertrophycardiomyocyteheart failuremelanocortin 1 receptor
spellingShingle Anni Suominen
Aino Suni
Saku Ruohonen
Zoltán Szabó
Lotta Pohjolainen
Minying Cai
Eriika Savontaus
Virpi Talman
Risto Kerkelä
Petteri Rinne
Melanocortin 1 Receptor Regulates Pathological and Physiological Cardiac Remodeling
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
cardiac hypertrophy
cardiomyocyte
heart failure
melanocortin 1 receptor
title Melanocortin 1 Receptor Regulates Pathological and Physiological Cardiac Remodeling
title_full Melanocortin 1 Receptor Regulates Pathological and Physiological Cardiac Remodeling
title_fullStr Melanocortin 1 Receptor Regulates Pathological and Physiological Cardiac Remodeling
title_full_unstemmed Melanocortin 1 Receptor Regulates Pathological and Physiological Cardiac Remodeling
title_short Melanocortin 1 Receptor Regulates Pathological and Physiological Cardiac Remodeling
title_sort melanocortin 1 receptor regulates pathological and physiological cardiac remodeling
topic cardiac hypertrophy
cardiomyocyte
heart failure
melanocortin 1 receptor
url https://www.ahajournals.org/doi/10.1161/JAHA.124.037961
work_keys_str_mv AT annisuominen melanocortin1receptorregulatespathologicalandphysiologicalcardiacremodeling
AT ainosuni melanocortin1receptorregulatespathologicalandphysiologicalcardiacremodeling
AT sakuruohonen melanocortin1receptorregulatespathologicalandphysiologicalcardiacremodeling
AT zoltanszabo melanocortin1receptorregulatespathologicalandphysiologicalcardiacremodeling
AT lottapohjolainen melanocortin1receptorregulatespathologicalandphysiologicalcardiacremodeling
AT minyingcai melanocortin1receptorregulatespathologicalandphysiologicalcardiacremodeling
AT eriikasavontaus melanocortin1receptorregulatespathologicalandphysiologicalcardiacremodeling
AT virpitalman melanocortin1receptorregulatespathologicalandphysiologicalcardiacremodeling
AT ristokerkela melanocortin1receptorregulatespathologicalandphysiologicalcardiacremodeling
AT petteririnne melanocortin1receptorregulatespathologicalandphysiologicalcardiacremodeling